Abiopharma

Szwarcberg Javier B. 🟡 adjusted position in 0 shares (2 derivative) of SPRUCE BIOSCIENCES, INC. (SPRB) at $344.25 ($4.5M) Transaction Date: Dec 11, 2025 | Filing ID: 000008

📋 Atlas Venture Fund X, L.P. (Shareholder) plans to sell 37K shares of Disc Medicine, Inc. (at $92.00 each, total $3.4M) Filed: Dec 15, 2025 | ID: 000095

SIMPSON CAMILLA V 🟡 adjusted position in 0 shares (10 derivative) of SPRUCE BIOSCIENCES, INC. (SPRB) at $1,143.00 Transaction Date: Dec 11, 2025 | Filing ID: 000007

Barretto-Ko Percival 🟡 adjusted position in 0 shares (2 derivative) of SPRUCE BIOSCIENCES, INC. (SPRB) at $169.50 Transaction Date: Dec 11, 2025 | Filing ID: 000003

Walbert Keli 🟢 acquired 3.4K shares (1 derivative) of SPRUCE BIOSCIENCES, INC. (SPRB) at $88.41 Transaction Date: Dec 11, 2025 | Filing ID: 000007

New Form 3 - SPRUCE BIOSCIENCES, INC. Filed: 2025-12-15 AccNo: 0002051489-25-000006 Size: 9 KB

📋 Atlas Venture Associates XII, L.P. (Shareholder) plans to sell 7K shares of Disc Medicine, Inc. (at $92.00 each, total $629K) Filed: Dec 15, 2025 | ID: 000094

Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger

Barack Louis Jon 🟢 acquired 500.0K shares (1 derivative) of Jushi Holdings Inc. (JUSH/JUSHF) at $0.50 Transaction Date: Dec 11, 2025 | Filing ID: 057190

ResMed Inc. Daily Stock Update

MOSIER MICHELLE O 🟢 acquired 300.0K shares (1 derivative) of Jushi Holdings Inc. (JUSH/JUSHF) at $0.50 Transaction Date: Dec 11, 2025 | Filing ID: 057188

Director Cross Benjamin 🟢 acquired 100.0K shares (1 derivative) of Jushi Holdings Inc. (JUSH/JUSHF) at $0.50 Transaction Date: Dec 11, 2025 | Filing ID: 057186

Director HAHN MARINA 🟢 acquired 100.0K shares (1 derivative) of Jushi Holdings Inc. (JUSH/JUSHF) at $0.50 Transaction Date: Dec 11, 2025 | Filing ID: 057184

Director Monroe Stephen 🟢 acquired 100.0K shares (1 derivative) of Jushi Holdings Inc. (JUSH/JUSHF) at $0.50 Transaction Date: Dec 11, 2025 | Filing ID: 057182

📋 Richard Markus (Officer) plans to sell 10K shares of Arcus Biosciences, Inc. (at $21.90 each, total $219K) Filed: Dec 15, 2025 | ID: 000003